Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches
Frontiers in Oncology · 02.04.2024 · 14
DOI: 10.3389/fonc.2024.1380358 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 02.04.2024. Verfasst von Claudia Bozzini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Internal Medicine, University of Verona, Verona, Italy. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Anemia is common in cancer patients and impacts on quality of life and prognosis. It is typically multifactorial, often involving different pathophysiological mechanisms, making treatment a difficult task. In patients undergoing active anticancer treatments like chemotherapy, decreased red blood cell (RBC) production due to myelosuppression generally predominates, but absolute or functional iron deficiency frequently coexists. Current treatments for chemotherapy-related anemia include blood transfusions, erythropoiesis-stimulating agents, and iron supplementation. Each option has limitations, and there is an urgent need for novel approaches. After decades of relative immobilism, several promising anti-anemic drugs are now entering the clinical scenario. Emerging novel classes of anti-anemic drugs recently introduced or in development for other types of anemia include activin receptor ligand traps, hypoxia-inducible factor-prolyl hydroxylase inhibitors, and hepcidin antagonists. Here, we discuss their possible role in the treatment of anemia observed in patients receiving anticancer therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Section of Internal Medicine, University of Verona, Verona, Italy.
- EuroBloodNet Referral Center, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.
- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Zitieren
APA
Bozzini, C., Busti, F., Marchi, G., Vianello, A., Cerchione, C., Martinelli, G., & Girelli, D. (2024). Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1380358
Vancouver
Bozzini C, Busti F, Marchi G, Vianello A, Cerchione C, Martinelli G, et al. Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1380358
BibTeX
@article{Bozzini2024,
author = {Bozzini, Claudia and Busti, Fabiana and Marchi, Giacomo and Vianello, Alice and Cerchione, Claudio and Martinelli, Giovanni and Girelli, Domenico},
title = {Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1380358}
}
EUVIMED